Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer

Yoshikazu Johmura(Tokyo University of Science), Makoto Nakanishi(Tokyo University of Science)
Journal of Clinical Investigation
November 11, 2018
Cited by 75


Related Papers